Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Gallagher

Showing results (291-300 of 300) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 300 results.
Cell Death & Disease|October 20, 2017
CD10<sup>-</sup>/ALDH<sup>-</sup> cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchyBrendan Ffrench, Claudia Gasch, Karsten Hokamp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2023
Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA)Marianne Holm, William R MacWright, Nimesh Poudyal, et al.
Journal of Ovarian Research|December 18, 2009
Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patientsMichael F Gallagher, Richard J Flavin, Salah A Elbaruni, et al.
Nature|December 22, 1994
A protein kinase involved in the regulation of inflammatory cytokine biosynthesisJ C Lee, J T Laydon, P C McDonnell, et al.
Pathology, Research and Practice|December 16, 2023
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancerMark Bates, Dorinda Mullen, Eimear Lee, et al.
Cell Death and Differentiation|September 9, 2017
MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cellsGomaa Sulaiman, Aoife Cooke, Brendan Ffrench, et al.
British Journal of Pharmacology|April 27, 2005
Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375Stephen A Douglas, David J Behm, Nambi V Aiyar, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2020
The pseudo-caspase FLIP(L) regulates cell fate following p53 activationAndrea Lees, Alexander J McIntyre, Nyree T Crawford, et al.
Bioorganic & Medicinal Chemistry|January 1, 1997
Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinaseT F Gallagher, G L Seibel, S Kassis, et al.
Plos One|July 1, 2014
The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancerCharles J d'Adhemar, Cathy D Spillane, Michael F Gallagher, et al.
Pageof 30

Showing results (291-300 of 300) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 300 results.
Cell Death & Disease|October 20, 2017
CD10<sup>-</sup>/ALDH<sup>-</sup> cells are the sole cisplatin-resistant component of a novel ovarian cancer stem cell hierarchyBrendan Ffrench, Claudia Gasch, Karsten Hokamp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2023
Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA)Marianne Holm, William R MacWright, Nimesh Poudyal, et al.
Journal of Ovarian Research|December 18, 2009
Regulation of microRNA biosynthesis and expression in 2102Ep embryonal carcinoma stem cells is mirrored in ovarian serous adenocarcinoma patientsMichael F Gallagher, Richard J Flavin, Salah A Elbaruni, et al.
Nature|December 22, 1994
A protein kinase involved in the regulation of inflammatory cytokine biosynthesisJ C Lee, J T Laydon, P C McDonnell, et al.
Pathology, Research and Practice|December 16, 2023
P53 and TLR4 expression are prognostic markers informing progression free survival of advanced stage high grade serous ovarian cancerMark Bates, Dorinda Mullen, Eimear Lee, et al.
Cell Death and Differentiation|September 9, 2017
MyD88 is an essential component of retinoic acid-induced differentiation in human pluripotent embryonal carcinoma cellsGomaa Sulaiman, Aoife Cooke, Brendan Ffrench, et al.
British Journal of Pharmacology|April 27, 2005
Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375Stephen A Douglas, David J Behm, Nambi V Aiyar, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2020
The pseudo-caspase FLIP(L) regulates cell fate following p53 activationAndrea Lees, Alexander J McIntyre, Nyree T Crawford, et al.
Bioorganic & Medicinal Chemistry|January 1, 1997
Regulation of stress-induced cytokine production by pyridinylimidazoles; inhibition of CSBP kinaseT F Gallagher, G L Seibel, S Kassis, et al.
Plos One|July 1, 2014
The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancerCharles J d'Adhemar, Cathy D Spillane, Michael F Gallagher, et al.
Pageof 30